Halozyme Therapeutics (HALO) Fair Value & DCF
HALO$100.27-0.40 -0.40%
Market cap$11.43BEnterprise value$16.78BRevenue (TTM)$1.66BMarket positionTop 25%
Score
69
Bullish
Value
61
Quality
85
Growth
62
Halozyme Therapeutics, Inc. (HALO) trades at $100.27 on $11.43B of equity value, with a trailing P/E of 27.64. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.